About Param Capital
Param Capital is a venture capital firm founded in 1993. It is primarily based out of Mumbai, India. As of Oct 2025, Param Capital has invested in 9 companies. It primarily invests in Series A round in India based startups. Its investments are spread across a wide range of sectors from EdTech to Consumer and Retail. Most recently it participated in the $***** Series A round of Intron Life Sciences A lot of funds co-invest with Param Capital, with names like Anchorage Capital Partners sharing a substantial percentage of its portfolio. Param Capital has team of 4 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Unattributed & 4 more
Portfolio Soonicorns
Param Capital's List of Top Investments
Param Capital has a portfolio of 9 companies. Their most notable investments include Qucev and Intron Life Sciences.Their portfolio spans across and India. They have invested in EdTech, Consumer, Retail and 9 other sectors, across stages such as Series A, Unattributed and 4 more. Here is the list of top investments by Param Capital:1. Qucev
Platform offering electric commercial vehicles. It includes buses, 3‑wheelers, and trucks designed for sustainable, cost-effective transport.
Key facts about Qucev
- Founded Year: 2022
- Location: Hyderabad (India)
- Annual Revenue: 0 - ₹10 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $19.1M
- Employee Count: 82 as on May 31, 2025
- Investors: Enam Holdings, Volrado Venture Partners Fund and 12 Others
- Latest Funding Round: Series B, Sep 29, 2025, $*****
- Highlight: Editors' Pick
_1557740578380.png?format=webp&height=120&width=120){kind=logo}
Manufacturer and supplier of probiotics and biotech products. It focuses on poultry, aquaculture, and other animal and habitat health along with products for various other applications like bioremediation, agriculture and human health. It has expertise in identification, evaluation, research and the commercialization of probiotics and other biotech products.
Key facts about Intron Life Sciences
- Founded Year: 2018
- Location: Hyderabad (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $11.1M
- Employee Count: 177 as on Aug 31, 2025
- Investors: InvAscent, Param Capital Research and 8 Others
- Latest Funding Round: Series A, Oct 08, 2025, $*****
3. Melorra
Internet-first brand offering precious jewelry. The product catalog includes bracelets, earrings, rings, pendants, necklaces, bangles, nose pins, chains, and more. The company claims its products are designed using gold and diamond. The company also offers gold and silver coins. The platform also wedding gifts option.
Key facts about Melorra
- Founded Year: 2015
- Location: Bengaluru (India)
- Annual Revenue: ₹10 - ₹50 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $88.3M
- Employee Count: 133 as on Aug 31, 2025
- Investors: BlackSoil, DSP Mutual Fund and 82 Others
- Latest Funding Round: Series E, Jun 20, 2024, $*****
- Highlight: Editors' Pick
4. SM Toys
Manufacturer of plastic promotional toys and confectionery products with toy elements. It utilizes plastic injection technology for the food and toy industries. The company produces promotional toys and confectionery products. The company works with materials such as PVC, ABS, TPR, silicone, and TPE.
Key facts about SM Toys
- Founded Year: 2019
- Location: Indore (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $13M
- Employee Count: 44 as on May 31, 2025
- Investors: Sixth Sense Ventures, Viney Equity Market and 7 Others
- Latest Funding Round: Series A, Nov 26, 2024, $*****
- Highlight: Editors' Pick
5. Inc5 Shoes
Brand offering multi-category fashion products. It offers a range of fashion products, include boots, casual & formal shoes, sandals, slip ons, heels, flip flops, flats, handbags, and wallets.
Key facts about Inc5 Shoes
- Founded Year: 1998
- Location: Mumbai (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $11.7M
- Employee Count: 40 as on Aug 31, 2025
- Investors: Carpediem Capital, Param Capital and 7 Others
- Latest Funding Round: Unattributed, Oct 14, 2025, $*****
Param Capital's Year-on-Year Investment Trends
Param Capital has invested in 9 companies over the last 17 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 2 investments. Its most recent first time investment was in Intron Life Sciences and most recent follow-on round was in Melorra.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
Param Capital's Investments by Stage
Param Capital has made 2 investments in Series A stage with an average round size of $13M, 2 investments in Unattributed stage with an average round size of $10M and 1 investment in PE stage with an average round size of $384K.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Unattributed | 2 |
PE | 1 |
Seed | 1 |
Series B | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Param Capital's Investments by Sector
Param Capital has a diverse portfolio, with companies operating in the Sustainability Tech, Consumer, Consumer Goods, Auto Tech and EdTech. Notably, it has invested in 5 Consumer (B2C) companies, 3 Enterprise (B2B) companies, 3 Tech companies and at least 1 company focusing on Software.Sector | No. of Investments |
|---|---|
Sustainability Tech | 3 |
Consumer | 2 |
Consumer Goods | 2 |
Auto Tech | 1 |
EdTech | 1 |
Others | 7 |
Note: We have considered here, only first round of investments
Param Capital's Investments by Geography
Param Capital has made most investments in India (8).Param Capital's recent investments
Param Capital has not made any investment in 2026 so far.Here are the most recent investments by Param Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 2025 | India | Series A | 6876 | - | |
Sep 29, 2025 | India | Series B | 3851 | [+11] | |
Nov 26, 2024 | India | Series A | 8727 | ||
Oct 12, 2023 | India | Unattributed | 2497 | [+4] | |
Apr 13, 2022 | India | Series D | 4280 | [+16] |
Team profile of Param Capital
Param Capital has a team of 4 members located in India. Param Capital's team does not sit on the board of any company as of now.Co-investors of Param Capital
Over the past 17 years, 248 investors have co-invested in Param Capital's portfolio companies. This includes funds and angels.
- Invested before Param Capital: Barclays, Singularity AMC and 144 others have invested in rounds before Param Capital. There is 1 company where Barclays has invested before Param Capital and 1 company where Singularity AMC has invested before Param Capital.
- Top Co-investors of Param Capital: 58 investors entered a company along with Param Capital. These include investors like Anchorage Capital Partners (1 company).
- Invested after Param Capital: A total of 44 investors have invested in Param Capital's portfolio after their investments. Top Investors include Param Capital Research (1 company), Manish Gupta (1 company) and Kavit Sutariya (1 company).
Recent News related to Param Capital
•
Strides' CDMO platform raises Rs 801 cr for growthIndiatimes•Oct 17, 2024•Strides Pharma Science, HBM Healthcare Investments, WhiteOak Capital Asset Management, Param Capital and 4 others
•
OneSource Specialty Pharma Limited announced that it has received INR 8.01 billion in funding from Passionate Investment Management Private Limited, Enam Holdings Pvt. Ltd, SBI Life Insurance Company Limited, Param Capital Research Private Limited, White Oak Capital Partners Pte. Ltd., HBM Partners Ltd.Stock Screener•Oct 16, 2024•Strides Pharma Science, HBM Healthcare Investments, White Oak Capital Partners, Param Capital and 1 other
